ALNYLAM PHARMACEUTICALS, INC. (ALNY) Price / FCF

ALNYLAM PHARMACEUTICALS, INC. Price-FCF Ratio

The price-to-free-cash-flow (P/FCF) ratio tells you how many dollars investors pay for each dollar of cash a company generates after paying for its capital spending. It is market capitalization divided by free cash flow over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher ratio means investors are paying more for each dollar of free cash flow; a negative ratio means the company spent more cash than it generated over those quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

• ALNYLAM PHARMACEUTICALS, INC. price-fcf ratio for the quarter ending 2025-12-31 was 113.13, a change of 827.5 year-over-year.
• ALNYLAM PHARMACEUTICALS, INC. price-fcf ratio for the quarter ending 2025-09-30 was 271.31, a 87.70% decline year-over-year.
• ALNYLAM PHARMACEUTICALS, INC. price-fcf ratio for the quarter ending 2025-06-30 was -547.5, a 661.19% decline year-over-year.
• ALNYLAM PHARMACEUTICALS, INC. price-fcf ratio for the quarter ending 2025-03-31 was -466.76, a 415.68% decline year-over-year.
• ALNYLAM PHARMACEUTICALS, INC. price-fcf ratio for fiscal 2025 was 113.13, a change of 827.5 from fiscal 2024.
• ALNYLAM PHARMACEUTICALS, INC. price-fcf ratio for fiscal 2024 was -714.37, a 224.44% decline from fiscal 2023.
• ALNYLAM PHARMACEUTICALS, INC. price-fcf ratio for fiscal 2023 was 574.04, a change of 622.06 from fiscal 2022.
• ALNYLAM PHARMACEUTICALS, INC. price-fcf ratio for fiscal 2022 was -48.02, a change of -19.64 from fiscal 2021.